Hengrui’s PD-1 Camrelizumab Moves Step Closer To US Filing

Positive Outcomes From Supporting Multiregional Trial

Hengrui to go abroad
Hengrui comes a step closer to bringing its PD-1 contender to the US • Source: Shutterstock

More from China

More from Focus On Asia